N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide

C23H19N3O2 — CID 16854555

IUPACN-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide
SMILESCc1ccc(-c2nnc(NC(=O)C(c3ccccc3)c3ccccc3)o2)cc1
InChIInChI=1S/C23H19N3O2/c1-16-12-14-19(15-13-16)22-25-26-23(28-22)24-21(27)20(17-8-4-2-5-9-17)18-10-6-3-7-11-18/h2-15,20H,1H3,(H,24,26,27)
InChIKeyXLDSBPSHYOJXQE-UHFFFAOYSA-N
MW369.42 g/mol
LogP4.82
Rot. Bonds5

About N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide

N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide (PubChem CID 16854555) has the molecular formula C23H19N3O2 and a molecular weight of 369.42 g/mol. Its IUPAC name is N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide.

Molecular Properties

Compound NameN-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide
PubChem CID16854555
Molecular FormulaC23H19N3O2
Molecular Weight369.42 g/mol
Exact Mass369.15
IUPAC NameN-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide
SMILESCc1ccc(-c2nnc(NC(=O)C(c3ccccc3)c3ccccc3)o2)cc1
InChIInChI=1S/C23H19N3O2/c1-16-12-14-19(15-13-16)22-25-26-23(28-22)24-21(27)20(17-8-4-2-5-9-17)18-10-6-3-7-11-18/h2-15,20H,1H3,(H,24,26,27)
InChIKeyXLDSBPSHYOJXQE-UHFFFAOYSA-N
XLogP4.82
TPSA68.02 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms28
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500369.42
LogP ≤ 54.82
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-methyl-N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]propanamide
CID 16854563
N-[5-(3-methylsulfanylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide
CID 7295032
2,2-diphenyl-N-[5-(3-propan-2-ylsulfonylphenyl)-1,3,4-oxadiazol-2-yl]acetamide
CID 41227501
N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide
CID 3342651
4-methyl-N-[(2S)-3-methyl-1-oxo-1-[(5-phenyl-1,3,4-oxadiazol-2-yl)amino]butan-2-yl]benzamide
CID 40987578
N-[5-(2,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide
CID 43972132
2,2-diphenyl-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]acetamide
CID 22661060
N-[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]-3,3-diphenylpropanamide
CID 43976657
[2-[[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]amino]-2-oxo-1-phenylethyl] benzoate
CID 10432772
2-bromo-2-methyl-N-(5-phenyl-1,3,4-oxadiazol-2-yl)propanamide
CID 114327579
N-[4-(6-methyl-1,3-benzoxazol-2-yl)phenyl]-2,2-diphenylacetamide
CID 4244780
5-(4-methylphenyl)-N-phenyl-1,3,4-oxadiazole-2-carboxamide
CID 110391121

Frequently Asked Questions

What is the IUPAC name of N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide?
The IUPAC name of N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide (CID 16854555) is N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide.
What is the SMILES notation for N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide?
The canonical SMILES for N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide is Cc1ccc(-c2nnc(NC(=O)C(c3ccccc3)c3ccccc3)o2)cc1.
What is the InChIKey of N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide?
The InChIKey is XLDSBPSHYOJXQE-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H19N3O2/c1-16-12-14-19(15-13-16)22-25-26-23(28-22)24-21(27)20(17-8-4-2-5-9-17)18-10-6-3-7-11-18/h2-15,20H,1H3,(H,24,26,27).
What are the key properties of N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide?
N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide has a molecular weight of 369.42 g/mol, XLogP of 4.82, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2,2-diphenylacetamide is sourced from PubChem (CID 16854555), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).